Market revenue in 2022 | USD 161.4 million |
Market revenue in 2030 | USD 209.5 million |
Growth rate | 3.3% (CAGR from 2022 to 2030) |
Largest segment | Viscosupplements |
Fastest growing segment | Synthetic |
Historical data | 2016 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Key Regions: Brazil , U.S. , UK , Japan , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 41.57% in 2022. Horizon Databook has segmented the Spain orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
The country has become one of the most popular medical tourism destinations for advanced medical care. The government is very proactive in developing its healthcare infrastructure by offering high-quality medical procedures at reasonable prices, easy accessibility, and strict safety regulations.
Furthermore, accessibility to skilled doctors is an attraction for medical tourists. A recent and substantial rise in the number of people suffering from obesity in Spain is further increasing risk of joint problems. For instance, one in six people is obese and two out of three men are overweight in the country.
Thus, increasing burden of diseases is expected to drive the market in Spain. Major factors contributing to growth of this market are advancements in medical technologies, increasing geriatric population, rising healthcare expenditure, and growing awareness.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into Spain orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account